Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Sanofi (SNW2) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
RilzabrutinibHealthy Volunteers, Renal ImpairmentPhase IRecruitingStudy to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to Matched Participants With Normal Renal FunctionSep 23, 2026
Rosuvastatin, Digoxin, Rilzabrutinib, CrestorHealthy VolunteerPhase IActive Not RecruitingAn Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 InhibitionSep 21, 2026
Bivalent Rsv+Hmpv Protein VaccineHealthy Volunteers, Respiratory Syncytial Virus, Human MetapneumovirusPhase IIRecruitingPhase 2b Study of a Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Protein Vaccine Candidate in Adults 60 Years of Age and OlderSep 03, 2026
Lunsekimig, Sar443765Chronic Obstructive Pulmonary DiseasePhase IIIRecruitingA Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)Aug 25, 2026
Acne Mrna VaccineAcnePhase IINot Yet RecruitingSafety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe AcneAug 04, 2026
Flu H5 Egg Pandemic Low Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic Medium Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, Without AdjuvantHealthy Volunteers, Influenzaphase1AndPhase2Not Yet RecruitingStudy to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.Jul 31, 2026
BelumosudilChronic Graft Versus Host DiseasePhase INot Yet RecruitingStudy to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male ParticipantsJul 21, 2026
Rsv+Hmpv Vaccine, Control Vaccine 3, Control Vaccine 4, Control Vaccine 2, Control Vaccine 1Healthy Volunteers, Respiratory Syncytial Virus Immunization, Human Metapneumovirus Immunizationphase1AndPhase2RecruitingPhase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and OlderJul 21, 2026
Menquadfi, MenhyciaHealthy Volunteers, Meningococcal InfectionPhase IIIRecruitingImmunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in ChinaJul 13, 2026
Sar448851Alzheimer's Disease, Dementia, Alzheimer's TypePhase IIRecruitingA Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's DiseaseJun 30, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sanofi SA (DE:SNW2) have in its pipeline
Sanofi DE:SNW2 is currently developing the following drugs: Rilzabrutinib, Rosuvastatin, Digoxin, Rilzabrutinib, Crestor, Bivalent Rsv+Hmpv Protein Vaccine, Lunsekimig, Sar443765, Acne Mrna Vaccine, Flu H5 Egg Pandemic Low Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic Medium Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, Without Adjuvant, Belumosudil, Rsv+Hmpv Vaccine, Control Vaccine 3, Control Vaccine 4, Control Vaccine 2, Control Vaccine 1, Menquadfi, Menhycia, Sar448851, Dupilumab, Dupilumab Coformulated With Berahyaluronidase Alfa, Sar231893, Dupixent, Blu-924, Sar447971, Sar445399, H5 Flu Investigational Medical Product 1, H5 Flu Imp 2, H5 Flu Imp 3, Rsv Imp 4, Rsv Imp 5, Rsv Imp 6, H5 Flu Imp 7, H5 Flu Imp 8, H5 Flu Imp 9, H5 Flu Imp 10, H5 Flu Imp 11, H5 Flu Imp 12, Itepekimab, Regn3500, Prednisone, Methylprednisolone, Tacrolimus, Mycophenolate Mofetil, Mycophenolate Sodium, Frexalimab, Rabbit Anti-Thymocyte Globulin, Sar441344, Pcv21 Vaccine, Varivax Vaccine, Vaxelis Vaccine, Hepatitis A Vaccine, 20Vpcv Licensed Vaccine, Rotavirus Vaccine, Measles Mumps And Rubella Vaccine, Frexalimab, Mri Contrast-Enhancing Preparations, Sarilumab, Fitusiran, Clotting Factor Concentrates Or Bypassing Agents, Antithrombin Concentrate, Moxifloxacin, Balinatunfib, Trivalent Vaccine Candidate, Bivalent Unlicensed Comparator, Monovalent Unlicensed Comparator, Biological/Vaccine: Monovalent Unlicensed Comparator, Pcv21, 20Vpcv, Prevnar 20, Dupilumab, Brivekimig, Sar448501, Vxb-241 60 Mcg, Vxb-241 120 Mcg, Vxb-241 240 Mcg, Vxb-241 480 Mcg, Arexvy 120 Mcg, Teriflunomide, Tolebrutinib, Teplizumab, Agalsidase Alfa, Agalsidase Beta, Venglustat, Migalastat, Normal Saline, Mrt5005. These drug candidates are in various stages of clinical development as the company works toward FDA approval.